Prestige Consumer Healthcare Inc. (PBH)

NYQ – Real Time Price. Currency in USD

52.49

-1.11 (-2.07%)

Market open: Aug 12, 2026, 11:04 AM EDT

53.60

0.00 (0.00%)

Previous after-hours: Aug 11, 2026, 7:34 PM EDT

Stock details

Previous close: 53.6$
Day's range: 52.39 - 53.75$
52-week range: 42.62 - 71.07$
Volume: 516 771
Average volume: 626 372
Beta: 0.31
EPS (TTM): 3.59
PE ratio (TTM): 15.01
Forward P/E: 11.69
Market cap: 2 539 274 369
Shares outstanding: 47 374 522
Dividend yield: N/A
Next earnings date: 2026-11-05
Sector: Healthcare
Industry: Drug Manufacturers - Specialty & Generic

About the company

Prestige Consumer Healthcare Inc., together with its subsidiaries, develops, manufactures, markets, distributes, and sells over the counter (OTC) health and personal care products in North America, Australia, and internationally. It operates in two segments, North American OTC Healthcare and International OTC Healthcare. The company offers analgesic powders under the BC and Goody's brand; various diaper rash treatments and sk... read more

CEO: Ronald Lombardi
Country: United States
IPO Date: 2005-02-10
Employees: 890
Fiscal Year End: April - March
Website: https://www.prestigebrands.com

Revenue Breakdown

North American Over-the-counter Healthcare / 83.91%

International Over-the-counter Healthcare / 16.09%

News

No Data

There are no news for this stock.

Chart: PBH

Loading Chart...

Overall Score

5.2 / 1052%

Octagon View

Strength & Weakness

Total debt $2.1B significantly exceeds cash reserves ($89.1M), raising financial stability concerns

Total current assets $496.8M exceed Total current liabilities $153.8M, highlighting excellent liquidity

Debt-to-equity ratio (1.1) is near the industry average, reflecting balanced leverage

Interest coverage ratio (4x) indicates the company easily manages its debt payments

The company generates positive free cash flow $67.1M, supporting its financial health

Financial Strength

NAME	RATIO	INDUSTRY	SCORE
Current ratio	3.23	2.52	10
Quick ratio	1.99	1.78	10
Debt to Equity	1.08	-0.80	6.0
Debt to Assets	0.45	0.73	5.0
Interest coverage	3.77	-13.90	9.0
Weighted average score			8.0

Debt to Assets

Financial

Values in USD
(B=Billions, M=Millions, K=Thousands)

Values in USD (B=Billions, M=Millions, K=Thousands)

METRIC	2022	2023	2024	2025	TTM
Total Revenue	1.13B	1.13B	1.14B	1.09B	1.10B
Gross Profit	600M	602M	613M	575M	570M
Operating Income	348M	342M	349M	309M	290M
Net Income	-82M	209M	215M	190M	172M
EBITDA	387M	373M	379M	341M	323M

Current Ratio

Revenue & Net Income

Cashflow

Margin Ratios

Profitability

NAME	RATIO	INDUSTRY	SCORE
Gross margin %	49.11	49.73	9.0
Operating margin %	19.77	0.39	9.0
Net margin %	10.98	-50.32	9.0
EBITDA margin %	23.06	-16.02	7.0
Cash flow margin %	26.64	124.71	10
Weighted average score			8.8

Net Margin

Effectiveness

NAME	RATIO	INDUSTRY	SCORE
ROA	5.29	-42.45	7.0
ROE	10.24	-63.95	7.0
ROIC	6.31	-2.18	6.0
ROCE	2.06	42.71	5.0
Weighted average score			6.3

Estimated EPS vs Actual EPS

Forecast

NAME	REVENUE GROWTH	EPS GROWTH	SCORE
Current quarter	17.51	0.52	5.5
Next quarter	21.6	8.55	8.0
Current year	16.61	4.28	6.5
Next year	6.06	11.17	6.0
Weighted average score			6.5

Analyst Rating

Growth

NAME	REVENUE	NET INCOME	EPS	FCF	SCORE
Q/Q	-5.64	-45.89	-20.32	78.27	3.3
Y/Y	6.48	-38.52	3.16	-14.18	2.8
3y average	-1.12	115.18	1.42	3.6	4.5
5y average	3.11	46.04	6.65	3.36	5.8
Weighted average score					4.1

Revenue Growth Rate vs. Industry

Valuation

NAME	RATIO	INDUSTRY	SCORE
P/E	14.85	13.57	6.2
PEG (5yr expected)	1.62	0.41	5.0
P/S	2.31	-0.30	4.0
P/B	1.31	6.01	7.6
Weighted average score			5.7

DCF Model

DCF Model Period5 years

Discount rate8%

Perpetual growth rate3%

Revenue 5 year CAGR4.63%

FCF 5 year CAGR4

Fair value117.74$

Stock price53.15$

Dividend

NAME	CURRENT	INDUSTRY	SCORE
Dividend yield	0.00	N/A	1.0
Payout ratio	0.00	N/A	1.0
5-year dividend growth rate	N/A	N/A	1.0
Years of dividend increase	N/A	N/A	1.0
Weighted average score			1.0

Fair Value

$117.74

UndervaluedStock priceOvervalued

$53.15

Economic Moat

NAME	SCALE	SCORE
Market share	None	1.0
Intangible assets	None	1.0
Switching costs	None	1.0
Network effect	None	1.0
Economies of scale	None	1.0
Weighted average score		1.0

About the company

CEO

Ronald Lombardi

Country

United States

IPO Date

2005-02-10

Employees

890

Fiscal Year End

April - March

Website

https://www.prestigebrands.com

NAME

RATIO

INDUSTRY

5Y TREND

SCORE

Current ratio

3.23

2.52

Quick ratio

1.99

1.78

Debt to Equity

1.08

-0.80

6.0

Debt to Assets

0.45

0.73

5.0

Interest coverage

3.77

-13.90

9.0

Weighted average score

8.0

METRIC

2022

2023

2024

2025

TTM

Total Revenue

1.13B

1.14B

1.09B

1.10B

Gross Profit

600M

602M

613M

575M

570M

Operating Income

348M

342M

349M

309M

290M

Net Income

-82M

209M

215M

190M

172M

EBITDA

387M

373M

379M

341M

323M

NAME

RATIO

INDUSTRY

5Y TREND

SCORE

Gross margin %

49.11

49.73

9.0

Operating margin %

19.77

0.39

9.0

Net margin %

10.98

-50.32

9.0

EBITDA margin %

23.06

-16.02

7.0

Cash flow margin %

26.64

124.71

Weighted average score

8.8

NAME

RATIO

INDUSTRY

5Y TREND

SCORE

ROA

5.29

-42.45

7.0

ROE

10.24

-63.95

7.0

ROIC

6.31

-2.18

6.0

ROCE

2.06

42.71

5.0

Weighted average score

6.3

NAME

REVENUE GROWTH

EPS GROWTH

SCORE

Current quarter

17.51

0.52

5.5

Next quarter

21.6

8.55

8.0

Current year

16.61

4.28

6.5

Next year

6.06

11.17

6.0

Weighted average score

6.5

NAME

REVENUE

NET INCOME

EPS

FCF

SCORE

Q/Q

-5.64

-45.89

-20.32

78.27

3.3

Y/Y

6.48

-38.52

3.16

-14.18

2.8

3y average

-1.12

115.18

1.42

3.6

4.5

5y average

3.11

46.04

6.65

3.36

5.8

Weighted average score

4.1

NAME

RATIO

INDUSTRY

5Q TREND

SCORE

P/E

14.85

13.57

6.2

PEG (5yr expected)

1.62

0.41

5.0

P/S

2.31

-0.30

4.0

P/B

1.31

6.01

7.6

Weighted average score

5.7

NAME

CURRENT

INDUSTRY

SCORE

Dividend yield

0.00

N/A

1.0

Payout ratio

0.00

N/A

1.0

5-year dividend growth rate

N/A

1.0

Years of dividend increase

N/A

1.0

Weighted average score

1.0

NAME

SCALE

SCORE

Market share

None

1.0

Intangible assets

None

1.0

Switching costs

None

1.0

Network effect

None

1.0

Economies of scale

None

1.0

Weighted average score

1.0

Search stocks

Prestige Consumer Healthcare Inc. (PBH)

Get all premium features to the best stock analysis tool

Finranks

Company

Contact us

Follow us

Prestige Consumer Healthcare Inc. (PBH)

Stock details

About the company

Revenue Breakdown

News

Chart: PBH

Overall Score

Octagon View

Strength & Weakness

Financial Strength

Debt to Assets

Financial

Current Ratio

Revenue & Net Income

Cashflow

Margin Ratios

Profitability

Net Margin

Effectiveness

Estimated EPS vs Actual EPS

Forecast

Analyst Rating

Growth

Revenue Growth Rate vs. Industry

Valuation

DCF Model

Dividend

Fair Value

$117.74

$53.15

Economic Moat

Stock details

About the company

Revenue Breakdown

News

Chart: PBH

Overall Score

Octagon View

Strength & Weakness

Financial Strength

Debt to Assets

Financial

Current Ratio

Revenue & Net Income

Cashflow

Margin Ratios

Profitability

Net Margin

Effectiveness

Estimated EPS vs Actual EPS

Forecast

Analyst Rating

Growth

Revenue Growth Rate vs. Industry

Valuation

DCF Model

Dividend

Fair Value

$117.74

$53.15

Economic Moat